
Please try another search
BCAL Diagnostics Limited, a screening and diagnostic company, engages in developing a novel blood screening test to improve the diagnosis and monitoring of breast cancer. It develops BREASTESTplus, a first-in-class blood test designed to be used alongside standard mammogram in breast cancer screening. The company also develops BREASTEST, BCAL Diagnostics, and BCAL Dx. The company was incorporated in 2010 and is headquartered in Sydney, Australia.
Name | Age | Since | Title |
---|---|---|---|
Jayne Andrea Shaw | - | 2010 | Co-Founder & Executive Chairman |
Jonathan Alfred Grey Trollip | 67 | 2020 | Independent Non-Executive Director |
John G. Hurrell | - | 2022 | Independent Non-Executive Director & Consultant |
David Gregory Darling | - | 2024 | Non-Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review